| Target Price | $53.75 |
| Price | $31.16 |
| Potential |
72.48%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Nanobiotix - ADR 2027 .
The average Nanobiotix - ADR target price is $53.75.
This is
72.48%
register free of charge
$71.39
129.10%
register free of charge
$38.91
24.88%
register free of charge
|
|
| A rating was issued by 12 analysts: 10 Analysts recommend Nanobiotix - ADR to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Nanobiotix - ADR stock has an average upside potential 2027 of
72.48%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 8.89 | 46.40 |
| 167.60% | 421.91% | |
| EBITDA Margin | -399.33% | -39.30% |
| 169.40% | 90.16% | |
| Net Margin | -305.40% | -68.41% |
| 152.02% | 77.60% |
7 Analysts have issued a sales forecast Nanobiotix - ADR 2026 . The average Nanobiotix - ADR sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Nanobiotix - ADR EBITDA forecast 2026. The average Nanobiotix - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Nanobiotix - ADR Analysts have issued a net profit forecast 2026. The average Nanobiotix - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.57 | -0.66 |
| 65.03% | 15.79% | |
| P/E | negative | |
| EV/Sales | 35.16 |
7 Analysts have issued a Nanobiotix - ADR forecast for earnings per share. The average Nanobiotix - ADR EPS is
This results in the following potential growth metrics and future valuations:
Nanobiotix - ADR...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 02 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


